I discovered a British study involving two girls aged four years twin cell responsible for leukemia in children.
The results of the study was able to reach a more precise treatments and less harmful for children infected with the disease, which is also known as "the Yukemia."
The team found that bone marrow researcher at the twins Olivia and Isabella Murphy has been given to the cells, "causing cancer of the blood," although only one of them had contracted the disease so far.
According to the study published in the journal "Science" that the cells are subject to two to Tefrtin cells become cancerous.
The cancer starts when the blood accounts for the production of white blood cells on the bone marrow, making it unable to produce red blood cells adequately.
The cancer of the blood and lymphatic tumors (lymphoma) half of cancers suffered by children.
The Olivia had suffered acute leukemia was aged for two years, while her sister Isabella did not suffer the disease.
Cancer begins when blood accounts for the production of white blood cells on the bone marrow, making it unable to produce red blood cells adequately
The researchers found that when cancer cells first skipped because of their genes changed after the break in the chain of DNA and heal differently, which is the order of its elements, while those cells remained unchanged at the second.
It is normal to be when the two girls Klte cancer cells that cause the blood as it facilitates the transition between the two fetuses in the womb. But the second mutation was necessary to start a particular disease. It may be the cause of inflammation of the second boom.
The doctors are continuing tests on Isabella in anticipation of the mandate of the disease, but they expect that the cancer cells then disappear completely when they reach adulthood.
Believed to be 1 percent of Britons are born with cancer cells, as the case of the two girls, and within this figure, see 1 percent surge necessary to cause the disease.
These cells do not deserve to pass the person harsh treatments necessary, given the weakness of the possibility of a second mutation and leukemia.
And Professor Tariq Anwar, who led the study, he should now find a point of weakness can be targeted cancer cells in which to eliminate them.
The results of the study was able to reach a more precise treatments and less harmful for children infected with the disease, which is also known as "the Yukemia."
The team found that bone marrow researcher at the twins Olivia and Isabella Murphy has been given to the cells, "causing cancer of the blood," although only one of them had contracted the disease so far.
According to the study published in the journal "Science" that the cells are subject to two to Tefrtin cells become cancerous.
The cancer starts when the blood accounts for the production of white blood cells on the bone marrow, making it unable to produce red blood cells adequately.
The cancer of the blood and lymphatic tumors (lymphoma) half of cancers suffered by children.
The Olivia had suffered acute leukemia was aged for two years, while her sister Isabella did not suffer the disease.
Cancer begins when blood accounts for the production of white blood cells on the bone marrow, making it unable to produce red blood cells adequately
The researchers found that when cancer cells first skipped because of their genes changed after the break in the chain of DNA and heal differently, which is the order of its elements, while those cells remained unchanged at the second.
It is normal to be when the two girls Klte cancer cells that cause the blood as it facilitates the transition between the two fetuses in the womb. But the second mutation was necessary to start a particular disease. It may be the cause of inflammation of the second boom.
The doctors are continuing tests on Isabella in anticipation of the mandate of the disease, but they expect that the cancer cells then disappear completely when they reach adulthood.
Believed to be 1 percent of Britons are born with cancer cells, as the case of the two girls, and within this figure, see 1 percent surge necessary to cause the disease.
These cells do not deserve to pass the person harsh treatments necessary, given the weakness of the possibility of a second mutation and leukemia.
And Professor Tariq Anwar, who led the study, he should now find a point of weakness can be targeted cancer cells in which to eliminate them.
